Concepedia

Sarah Kate Lane-Reticker

SK

6

Publications

1K

Citations

6

H-Index

2017

Active since

Affiliations

Broad Institute(Current)

Massachusetts General Hospital

Center for Cancer Research

Massachusetts Institute of Technology

Harvard University

Sarah Kate Lane-Reticker is an author at Broad Institute specializing in immunology, medicine, and crispr.

ORCID

Top concepts

Publications per year

2017–2024

6

Publications

6

Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade

Jeffrey J. Ishizuka, Robert T. Manguso, Collins Cheruiyot et al. · Nature · 2018 · 688 citations · Full text

, , +8

In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer

Juan Dubrot, Peter P. Du, Sarah Kate Lane-Reticker et al. · Nature Immunology · 2022 · 198 citations

, , +10

In vivo screens using a selective CRISPR antigen removal lentiviral vector system reveal immune dependencies in renal cell carcinoma

Juan Dubrot, Sarah Kate Lane-Reticker, Emily Kessler et al. · Immunity · 2021 · 90 citations · Full text

, , +5

Precocious Interleukin 21 Expression in Naive Mice Identifies a Natural Helper Cell Population in Autoimmune Disease

Elisabeth A. Marnik, Xulong Wang, Thomas J. Sproule et al. · Cell Reports · 2017 · 21 citations · Full text

Targeting the aminopeptidase ERAP enhances antitumor immunity by disrupting the NKG2A-HLA-E inhibitory checkpoint

Hsiao‐Wei Tsao, Seth Anderson, Kenneth J. Finn et al. · Immunity · 2024 · 14 citations · Full text

Rows per page

1–5 of 6